The article you are looking for is not available.
Perhaps you would be interested in our most recent articles.
Isolation technology has significantly improved our ability to manufacture sterile drug products aseptically. Its performance far exceeds that of other aseptic technologies and has been successfully ...
read more
The “holy grail” of patient-centricity is the transition from injectables to oral dosages, a move that drastically patient compliance and quality of life.
read more
In biopharmaceutical development, product quality is the highest priority. The resulting structure must be exactly as designed and of exceptional purity.
read more
Many early adopters of rapid methods later went back to traditional methods. What were these technologies and when did early adopters continue using them?
read more
When properly integrated through appropriate design planning, validation and alignment with regulatory expectations, continuous monitoring can strengthen contamination control strategies and support ...
read more
GLP-1s have generated large amounts of new safety work. Pharmacovigilance systems are struggling to cope with the volume and complexity.
read more
Chromatography has an important role, but relying on it too long may cost of goods, extend timelines, and complicate regulatory submissions.
read more
Use of MPN for resolution of anomalous results assumes a log-linear death curve, which has never been established in a bi-phasic system.
read more
Lypophilization helps stabilize fragile new modalities, including messenger RNA and the advanced formulation vehicles that deliver them.
read more
Many patients abandon ADC therapies due to the associated toxicities. The next major leap requires designing targeted small molecules for conjugation.
read more